NEW YORK, April 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICE Medical, Inc. ("ICU Medical" or the "Company") (NASDAQ: ICUI). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/icui.
The investigation concerns whether ICU Medical and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On April 18, 2017, after-market hours, ICU Medical revealed that it had received a subpoena from the U.S. Department of Justice requesting "documents regarding the manufacturing, selling, pricing and shortages of intravenous solutions, including saline" that it gained when it acquired the infusion systems business of Pfizer Inc.'s Hospira unit. Following this news, ICU Medica stock dropped as much as $1.55per share, or 1.06%, during intraday trading on April 19, 2017.
If you are aware of any facts relating to this investigation, or purchased shares of ICU Medical, you can assist this investigation by visiting the firm's site: www.bgandg.com/icui. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE Bronstein, Gewirtz & Grossman, LLC